Answers are grounded in this paper and cite their sources.
Fibrosarcomas (FS) of bone are a rare malignancy accounting for less than 5% of all primary malignant bone neoplasms. Diagnosis and treatment approaches of this entity are complex and require a skilled and experienced multidisciplinary team.Authors report their experience with a case of FS of humerus showing a pathologic complete response to neo-adjuvant chemotherapy based on adriamycin, cisplatin and ifosfamid. This approach allowed limb-sparing surgery with an excellent functional and psychological result.
No takes yet. Share an insight, caveat, or question.
Mesbahi et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: